This is of critical relevance considering that, beside facilitating viral entry, engagement of ACE2 by S1 triggers multiple detrimental signaling pathways known to participate in cellular responses, including inflammation, fibrosis and tissue damage (66), collectively contributing to COVID-19 severity. The gene discussed is ACE2; the disease is COVID-19.